Skip to content
The Nexus
DossierENTITY

Kathleen Clark

Coverage of Kathleen Clark in the Nexus archive.

Earliest in view: May 22 · 18:30 UTCMost recent: Jul 18 · 14:52 UTC
Co-mentioned in this coverage
Recent coverage
  • BUSINESSJul 18 · 14:52 UTCFORTUNE
    Trump monetizing his social media account is ‘odious’ and ‘brazen corruption’ — or an attempt to revive a 70% stock price crash since election

    Donald Trump's media company, Truth Social, plans to sell Wall Street traders early access to posts from high-ranking accounts, including potentially Trump's own, to profit from market-moving content. Critics label the move 'odious' and 'brazen corruption,' arguing it exploits the public by prioritizing financial interests over equitable information access.

  • POLITICSJul 17 · 21:40 UTCWPLG LOCAL 10 MIAMI
    Paying for early access to Trump's Truth Social could raise big money - and major ethical issues

    Donald Trump's media company plans to sell early access to posts from high-ranking accounts on Truth Social to Wall Street traders, potentially generating significant revenue while raising ethical concerns. The service, named Truth PSI, aims to provide milliseconds of early access to influence financial markets, with critics calling it corrupt and unethical.

  • BUSINESSJul 17 · 21:40 UTCWDIV CLICKONDETROIT
    Paying for early access to Trump's Truth Social could raise big money - and major ethical issues

    Donald Trump's Truth Social platform plans to offer Wall Street traders early access to posts from high-ranking accounts, potentially including his own, to generate revenue. This service, called Truth PSI, could create ethical concerns as Trump's posts have previously caused significant market fluctuations.

  • POLITICSJul 17 · 13:52 UTCFORTUNE
    Trump is selling millisecond access to his Truth Social blasts — and traders are already lining up

    President Trump's media company is offering paid high-speed access to Truth Social posts, including his own, allowing traders to profit from market-moving information. Critics argue this constitutes corruption and improper use of government power, while the company's stock has fallen sharply amid scrutiny of Trump's financial disclosures.

  • BUSINESSJul 16 · 19:27 UTCWTOP DC
    Trump media firm plans to sell high speed access to Truth Social posts, possibly Trump’s own

    President Donald Trump’s media company plans to sell high-speed access to Truth Social posts, including potentially his own, to allow institutions to profit from market movements. The service, called Truth PSI, aims to provide milliseconds-early access to posts from high-profile contributors like Trump, who is the platform’s top poster and major shareholder. Trump Media & Technology’s stock has dropped 70% since Trump took office.

  • BUSINESSJul 16 · 19:27 UTCWPLG LOCAL 10 MIAMI
    Trump media firm plans to sell high speed access to Truth Social posts, possibly Trump's own

    Trump's media company plans to sell high-speed access to Truth Social posts, including potentially his own, to institutions for financial market insights. Critics argue this creates a conflict of interest, as Trump, a major shareholder, would directly benefit from expedited information sharing. The service, called Truth PSI, aims to launch soon with pre-registered customers.

  • BUSINESSJul 16 · 19:27 UTCWDIV CLICKONDETROIT
    Trump media firm plans to sell high speed access to Truth Social posts, possibly Trump's own

    President Donald Trump's media company plans to sell high-speed access to Truth Social posts, including potentially his own, to institutions for profit. The service, Truth PSI, aims to provide milliseconds faster access to content that could impact financial markets. Critics argue this creates a conflict of interest as Trump, a major shareholder, would directly benefit from expedited dissemination of his posts.

  • POLITICSMay 22 · 18:30 UTCKFF HEALTH NEWS
    Trump Bought Stock in Eli Lilly as His Policies Gave the Drugmaker a Big Boost, Documents Show

    President Trump purchased between $680,000 and $1.18 million in stock in Eli Lilly and West Pharmaceutical Services in early 2025, shortly before the administration implemented policies that significantly benefited these companies, including advancing Medicare reimbursement for GLP-1 drugs and cracking down on cheaper generic competitors. Government ethics experts have raised concerns that the stock purchases undermine public trust by creating the appearance that Trump is personally profiting from administration actions. Congressional Democrats are calling for legislation to ban presidents from owning and trading stocks.